Attovia Therapeutics Prices IPO at $17 a Share
The offering gives the company an estimated $265.1 million in net proceeds.
Attovia Therapeutics, Inc. priced its initial public offering of 17 million shares at $17 a share, raising estimated net proceeds of $265.1 million.
The offering leaves Attovia with 43,029,017 shares outstanding and a resulting market capitalization of $731,493,289.
Underwriters may purchase an additional 2,550,000 shares through the over-allotment option, potentially expanding the public float.
*Source: Attovia Therapeutics prospectus.*